AK the American Bully gives Duke the horse a loving pet in this heartwarming clip. Enjoy!
AK the American Bully gives Duke the horse a loving pet in this heartwarming clip. Enjoy!
‘If you’re telling a story about a community and they’re not welcoming to you, then f*** off,’ said star
Once the preserve of gamers, virtual reality (VR) has been seized on by the financial sector as a way of enlivening home working for lonely traders or isolated executives and replicating real-world sales, networking or training events. "Working from home has massively accelerated the interest in virtual/online spaces," said Stuart Warner, head of technology at Fidelity International which manages $3.3 trillion in assets. Having internally explored VR and augmented reality (AR) technology, which unlike VR is not fully immersive and involves computer-generated elements being visible through a smartphone screen for example, Fidelity now aims to trial VR with its sales teams' interactions with clients.
DGAP-News: HYPOPORT SE / Key word(s): Market launch 24.11.2020 / 08:20 The issuer is solely responsible for the content of this announcement. Thanks to Europace and Smart InsurTech, Sparda BW enables payment protection insurance linked to mortgage finance to be taken out digitally Bancassurance: Europace credit platform and SMART INSUR insurance platform seamlessly integrated with each other for the first time Berlin, 24 November 2020. For the first time, Europace - the largest German transaction platform for mortgage finance, building finance products, and personal loans - and the web-based SMART INSUR insurance platform can communicate with each other directly. In cooperation with Sparda-Bank Baden-Württemberg eG (Sparda BW), a standard connection was developed that enables payment protection insurance to be taken out digitally in conjunction with a mortgage finance application. "We want to digitalise our processes and reduce manual tasks that take up a lot of time so that our advisors can focus more on looking after clients while administrative staff can concentrate on value-adding tasks," says Michael Lichtner, Back Office Head of Department at Sparda BW, explaining the reasons for the joint project. "This not only improves our efficiency but also enables us to avoid errors that might potentially occur in manual processes." Thanks to the cooperation between Smart InsurTech AG and Europace AG, both of which are wholly owned subsidiaries of Hypoport SE, an advisor who applies for mortgage finance for their client using Europace's Baufi Smart frontend receives an offer for payment protection insurance and thus benefits from the Smart Compare comparison tool. Smart Compare connects the mortgage finance advisors to the product supplier Credit Life, enabling a quote to be requested almost in real time. Stefan Münter, Co-CEO of Europace, adds: "We are delighted that Sparda BW, a long-standing customer of the credit platform, has teamed up with us for this project. The collaboration between the two Hypoport companies allows us to be a one-stop shop for Sparda BW, providing the best possible process for advisors and end clients. It was important for us to create a standard interface to the SMART INSUR insurance platform as it means we can offer a link to payment protection insurance as part of the mortgage finance application process for all prospective customers in future." Besides the synergies, another benefit of the interface between the credit and insurance platforms is the high level of data security because both systems are part of the Hypoport Group and thus no external service providers are involved. Care was taken to maintain a separation between the two companies, with each one working in their own domain and only with access to the data that it actually needs. "By combining the expertise of Europace and Smart InsurTech, we can make inroads into new markets," reports Marcus Rex, member of the Management Board of Smart InsurTech AG. "It provides the blueprint for the integration of further payment protection insurance products. Any such product can be integrated through the interface, so it opens up huge market potential." About Hypoport SE Hypoport SE is headquartered in Lübeck (Germany) and is the parent company of the Hypoport Group. The Group is a network of technology companies for the credit, real-estate and insurance industries with a workforce of more than 2,000 employees. It is grouped into four segments: Credit Platform, Private Clients, Real Estate Platform and Insurance Platform. The Credit Platform segment operates Europace, which is an online B2B financial marketplace and the largest German platform offering mortgages, building finance products and personal loans. A fully integrated system links more than 750 partners - banks, insurers and financial product distributors. Several thousand loan brokerage advisors execute approx. 35,000 transactions per month on Europace, generating a volume of more than €7 billion. Besides Europace, the FINMAS and GENOPACE sub-marketplaces and the B2B distribution companies Qualitypool and Starpool support the growth of the credit platform. The Private Clients segment, made up of the web-based, non-captive financial product distributor Dr. Klein Privatkunden and the consumer comparison portal Vergleich.de, brings together all business models aimed at directly advising consumers on mortgages, insurance or pension products. All real estate-related activities of the Hypoport Group, with the exception of mortgage finance, are grouped together in the Real Estate Platform segment (previously Institutional Clients) with the aim of digitalising the sale, valuation, financing and management of properties. The Insurance Platform segment operates SMART INSUR, a web-based B2B platform for advice, comparison of tariffs and the administration of insurance policies. The segment also incorporates the insurance unit of Qualitypool, a B2B distribution company. The shares of Hypoport SE are listed in the Prime Standard segment of the Frankfurt Stock Exchange (Deutsche Börse) and have been included in the SDAX since 2015. Contact Jan H. Pahl Investor Relations Manager Phone: +49 (0)30 / 42086 - 1942 Mobile: +49 (0)176 / 965 125 19 Email: email@example.com Hypoport SE Heidestraße 8 10557 Berlin www.hypoport.com Key data on Hypoport's shares ISIN DE 0005493365 WKN 549336 Stock exchanges symbol HYQ 24.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: HYPOPORT SE Heidestraße 8 10557 Berlin Germany Phone: +4930420861942 Fax: +49/30 42086-1999 E-mail: firstname.lastname@example.org Internet: www.hypoport.de ISIN: DE0005493365 WKN: 549336 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1150129 End of News DGAP News Service
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Diabetes Drug Delivery Devices Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The "Diabetes Drug Delivery Devices Market, 2020-2030" report features an extensive study of the current market landscape and the likely adoption of diabetes drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain. One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities for diabetes drug delivery devices. Based on multiple parameters, such as the number of commercialized devices, number of devices under development, price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the period 2020-2030. The report also features sales forecasts for the overall diabetes drug delivery devices market with a detailed market segmentation on the [A] type of device (pen-injectors, insulin pumps, conventional syringes and others), [B] route of administration (subcutaneous, intravenous and others), [C] diabetes type (type 1 diabetes and type 2 diabetes), [D] device usability (disposable and reusable) and [E] key geographies (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base and optimistic scenarios, which represent different tracks of the industry's evolution.Amongst other elements, the report includes: An overview of the current market landscape of diabetes drug delivery devices available for delivery of insulin and non-insulin drugs, including information on device specifications, such as type of device (insulin pump, pen-injector/autoinjector, jet injector, microneedle patch, nasal delivery system, insulin port, oral delivery system and inhalation device), stage of development (marketed, clinical and preclinical), route of administration (subcutaneous, intramuscular, transdermal, oral, intranasal and others), mode of drug delivery (invasive, minimally invasive and non-invasive), needle attributes (needleless, detachable needle, cannula, hidden needle and fixed needle), type of drug delivery system (mechanical method and electrical method), drug administration speed (fast and slow), device usability (disposable, reusable and reusable (disposable components)), diabetes type (type I diabetes, type II diabetes and diabetes type (unspecified)) and type of drug (insulin and non-insulin). In addition, the report present the details of the companies developing these devices, including information on type of developer (industry and non-industry), year of establishment, company size and location of headquarters.A detailed competitiveness analysis of diabetes drug delivery devices based on various relevant parameters, such as supplier power (based on the experience/expertise of the developer) and product specifications (type of device, route of administration, diabetes type, needle attributes, availability of needle safety system, self-administration potential, mode of drug delivery, device usability, drug administration speed and development stage).An analysis of the partnerships that have been inked by the stakeholders in this domain, during the period between 2015 and 2020, covering technology integration agreements, product development agreements, distribution agreements, acquisitions, product commercialization agreements, supply agreements, licensing agreements, product development and commercialization agreements and other relevant types of deals.Elaborate profiles of the prominent players developing diabetes drug delivery devices. Each company profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook.A review of recent initiatives undertaken by big pharma players engaged in this domain. It also features a benchmark analysis of top 10 big pharma players (in terms of annual revenues of 2019), based on their initiatives related to diabetes drug delivery devices. Key Topics Covered: 1. PREFACE1.1. Scope of the Report1.2. Research Methodology1.3. Chapter Outlines2. EXECUTIVE SUMMARY3. INTRODUCTION3.1. Chapter Overview3.2. An Overview of Diabetes3.2.1. Classification of Diabetes18.104.22.168. Type 1 Diabetes22.214.171.124. Type 2 Diabetes3.3. Route of Administration for Diabetes Drugs3.3.1. Buccal Route3.3.2. Inhalation Route3.3.3. Intradermal Route3.3.4. Intramuscular Route3.3.5. Intranasal Route3.3.6. Oral Route3.3.7. Subcutaneous Route3.4. Key Challenges Associated with Delivery of Diabetes Drugs3.5. Diabetes Drug Delivery Devices3.5.1. Implants3.5.2. Inhalation Devices3.5.3. Insulin Ports3.5.4. Insulin Pumps3.5.5. Jet Injectors3.5.6. Microneedle Patches3.5.7. Nasal Delivery Devices3.5.8. Pen-Injectors/Autoinjectors3.6. Concluding Remarks4. CURRENT MARKET LANDSCAPE4.1. Chapter Overview4.2. Diabetes Drug Delivery Devices: Overall Market Landscape4.2.1. Analysis by Type of Device4.2.2. Analysis by Stage of Development4.2.3. Analysis by Route of Administration4.2.4. Analysis by Mode of Drug Delivery4.2.5. Analysis by Needle Attributes4.2.6. Analysis by Type of Drug Delivery System4.2.7. Analysis by Drug Administration Speed4.2.8. Analysis by Device Usability4.2.9. Analysis by Diabetes Type4.2.10. Analysis by Type of Drug4.3. Diabetes Drug Delivery Devices: List of Developers4.3.1. Analysis by Type of Developer4.3.2. Analysis by Year of Establishment4.3.3. Analysis by Company Size4.3.4. Analysis by Location of Headquarters4.3.5. Leading Manufacturers: Analysis by Number of Products5. PRODUCT COMPETITIVENESS ANALYSIS5.1. Chapter Overview5.2. Assumptions and Methodology5.2.1. Product Competitive Analysis: Diabetes Drug Delivery Devices6. PARTNERSHIPS AND COLLABORATIONS6.1. Chapter Overview6.2. Partnership Models6.3. Diabetes Drug Delivery Devices: List of Partnerships and Collaborations6.3.1. Analysis by Year of Partnership6.3.2. Analysis by Type of Partnership6.3.3. Analysis by Year and Type of Partnership6.3.4. Analysis by Type of Device6.3.5. Most Active Players: Analysis by Number of Partnerships6.3.6. Geographical Analysis126.96.36.199. Region-wise Distribution188.8.131.52. Country-wise Distribution7. COMPANY PROFILES7.1. Chapter Overview7.2. Bigfoot Biomedical7.2.1. Company Overview7.2.2. Diabetes Drug Delivery Device Portfolio7.2.3. Recent Developments and Future Outlook7.3. Debiotech7.4. Haselmeier7.5. Medtronic7.6. Novo Nordisk7.7. Roche7.8. SOOIL7.9. Ypsomed8. DIABETES DRUG DELIVERY DEVICES RELATED INITIATIVES OF BIG PHARMA PLAYERS8.1. Chapter Overview8.2. Scope and Methodology8.3. Initiatives of Big Pharma Players8.3.1. Analysis by Diversity in Device Portfolio8.3.2. Analysis by Phase of Development8.3.3. Analysis by Diabetes Type8.3.4. Analysis by Type of Drug8.3.5. Analysis by Number of Partnerships8.4. Benchmark Analysis of Big Pharma Players9. MARKET SIZING AND OPPORTUNITY ANALYSIS9.1. Chapter Overview9.2. Forecast Methodology and Assumptions9.3. Overall Diabetes Drug Delivery Devices Market, 2020-20309.3.1. Diabetes Drug Delivery Devices Market, 2020-2030: Distribution by Type of Device9.3.2. Diabetes Drug Delivery Devices Market, 2020-2030: Distribution by Route of Administration9.3.3. Diabetes Drug Delivery Devices Market, 2020-2030: Distribution by Diabetes Type9.3.4. Diabetes Drug Delivery Devices Market, 2020-2030: Distribution by Device Usability9.3.5. Diabetes Drug Delivery Devices Market, 2020-2030: Geographical Distribution184.108.40.206. Diabetes Drug Delivery Devices Market in North America, 2020-20309.3.5.2. Diabetes Drug Delivery Devices Market in Europe, 2020-20309.3.5.3. Diabetes Drug Delivery Devices Market in Asia Pacific, 2020-20309.3.5.4. Diabetes Drug Delivery Devices Market in Rest of the World, 2020-203010. CONCLUDING REMARKS10.1. Chapter Overview10.2. Key Takeaways11. EXECUTIVE INSIGHTS12. APPENDIX 1: TABULATED DATA For more information about this report visit https://www.researchandmarkets.com/r/ia6njg Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Man at centre of South Australia lockdown 'extremely remorseful and deeply sorry'Solicitor acting for the 36-year-old man released a statement on Tuesday saying some information circulating was not ‘accurate’
EXCLUSIVE: Pete Davidson is taking on an iconic film character, James Stewart’s George Bailey. The Saturday Night Live actor and Maude Apatow (Euphoria), who recently starred together in The King of Staten Island, are reuniting for Ed Asner’s one-night-only live virtual celebrity table read of the 1946 holiday classic It’s A Wonderful Life, in which […]
Prime Minister Boris Johnson revealed details of the Government’s winter pandemic plan on Monday. Now, as England looks ahead to exiting the national lockdown, how have the tiers changed? Boris Johnson has confirmed that the national lockdown will end on December 2, to be replaced with the new tier system.
An investigation by Which? found 85% of products it tracked could be found cheaper or the same price in the six months before.
Taiwan President Tsai Ing-wen kicks off construction of the island's first indigenous submarine at a Kaohsiung shipyard, the latest move by the out-gunned democratic island to bolster its defence capabilities against increasingly bellicose threats from Beijing.
'I was 17 but they said I was 28': Home Office age rulings cost young refugees an educationTwo young people who arrived in the UK alone explain how they have been denied schooling – and hope for the future
As Ethiopia’s army declares daily victories, its people are being plunged into violence. Abiy Ahmed’s war against Tigrayan rebels endangers a fragile union whose collapse would destabilise the Horn of Africa
Hardman & Co Research 24-Nov-2020 / 07:15 GMT/BST Hardman & Co Research: Trading update ‒ main businesses performing solidly Chamberlin's recent trading update (23 November 2020) indicates that the group's main businesses are performing as previously indicated, with the company continuing to take appropriate operational strategic actions. The group has been financially de-risked but financial forecasts continue to be inappropriate given low visibility on business activity. Please click on the link below for the full report: https://www.hardmanandco.com/research/corporate-research/trading-update-%e2%80%92-main-businesses-performing-solidly/ If you are interested in meeting the company, you can register your interest by clicking on the above link To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.com Follow us on Twitter @HardmanandCo Contact: Paul Singer +44 20 7194 7622 firstname.lastname@example.org Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement. About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case. Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer. Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement. End of Announcement - EQS News Service
Global Industrial Lighting market is expected to grow by USD 1 billion as we reach 2024. Due to the impact of the COVID-19 pandemic in 2020.
Save on Purple Mattress deals at the Black Friday sale, featuring all the best Purple bed, pillow and mattress offers
Tom Brady’s Bucs will struggle to catch the conference-leading New Orleans Saints.
An opposition lawmaker called on Tuesday for Malaysia to outlaw online hate speech, accusing authorities of downplaying the gravity of an issue highlighted by a Reuters investigation into abuse on Facebook of Rohingya refugees and undocumented migrants. Citing the Reuters report on rising xenophobia online in Malaysia in the wake of the coronavirus epidemic, lawmaker Chan Foong Hin asked the Communications and Multimedia Ministry last week to state its plans to combat such hate speech.
French police used tear gas to dismantle a camp of several hundred migrants at a major Paris central plaza in the night between Monday and Tuesday. The migrants had set up camp after being cleared from several shelters in the region without being relocated. The camp appeared on Place de la République in Paris on Monday evening when volunteers helped set up 500 blue tents for migrants, most of them from Afghanistan, in an effort to draw attention to the plight of people during long waits for asylum.Police arrived to dismantle the camp around an hour later, picking up tents, sometimes with people still inside, to jeers and protests from volunteers and migrants. “They are too violent,” Shahbuddin, a 34-year-old Afghan, told AFP agency as he was forced out of his tent. “We just want a roof.” Police used tear gas to disperse what remained of the camp.The dismantling came a week after migrants were evacuated from makeshift shelters in the northern suburb of Saint-Denis without being relocated.No solution for migrants on streetsParis police have vowed to stop camps from forming in the capital in recent years, with the result that they have appeared in the surrounding suburbs instead. “This evening of protest had ended without a solution for more than 450 exiles. Only more violence and a non-welcoming policy from the state. Once again, these people will sleep on the street tonight,” tweeted NGO Utopia 56. “We’re here to show that we have nowhere else to go,” said Murtaza, 20, from Afghanistan. “We can’t live like animals, we just want to claim asylum.”Humanitarian groups say after clearing camps, migrants are sometimes taken to temporary housing but have to lasting solution to keep them off the streets. Government orders reportParis deputy mayor for housing Ian Brossart condemned what he called a “law and order response to a social situation”.French Interior Minister Gérald Darmanin said he found the images to be shocking and that he had ordered the police to explain the scene. “Some images of the dispersion of the illegal migrant camp at Place de la République are shocking,” Darmanin said. “I have requested a report on the circumstances from the police prefect by tomorrow [Tuesday] at midday.” The incidents come at a time the government is facing criticism over a proposal press freedom groups fear will be used to stop journalists filming and photographing police operations. (with newswires)
Britain's Octopus Energy on Tuesday announced plans to supply retail power customers in Germany, home to big established utilities but is open to newcomers. A fast growing start-up supplier in its home country Britain, Octopus said it aims to reach a mass clientele in Europe's biggest power market, where it bought Munich startup 4hundred last year on which it built the new firm. "Octopus Energy Germany is targeting one million customers by 2024 and committed to fuel this rapid expansion with an initial investment of 80 million euros ($95 million) in the market," it said in a statement.
The images of Olive Buller, shown on Antiques Roadshow and recognised by Carol Jephson, were taken during her time at Wrest Park in Bedfordshire.
Everything you need to know about the game